Cronos Group Inc. (CRON.TO)
CAD 2.53
(2.02%)
CAD 2.53
(2.02%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -71.8 Million USD | 59.27% |
| 2022 | -91.26 Million USD | -366.76% |
| 2021 | -192.28 Million USD | 113.86% |
| 2020 | -82.72 Million USD | 88.61% |
| 2019 | 1.59 Billion CAD | -12000.09% |
| 2018 | -18.84 Million CAD | -1442.23% |
| 2017 | -6.72 Million CAD | 35.9% |
| 2016 | -1.17 Million CAD | 70.7% |
| 2015 | 1.13 Million CAD | -79.94% |
| 2014 | -3.25 Million CAD | -259.75% |
| 2013 | -619.47 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.96 Million USD | -11.03% |
| 2024 Q1 | -7.96 Million USD | 47.99% |
| 2023 Q1 | -10.12 Million USD | -2175.28% |
| 2023 FY | - USD | 59.27% |
| 2023 Q4 | 25.4 Million USD | 225.06% |
| 2023 Q3 | -20.31 Million USD | -0.06% |
| 2023 Q2 | -20.3 Million USD | -100.51% |
| 2022 Q2 | -22.56 Million USD | -4.22% |
| 2022 FY | - USD | -366.76% |
| 2022 Q1 | -21.64 Million USD | -137.29% |
| 2022 Q4 | -445 Thousand USD | 97.43% |
| 2022 Q3 | -17.34 Million USD | 23.11% |
| 2021 Q4 | 58.04 Million USD | 216.72% |
| 2021 Q1 | -41.1 Million USD | 27.46% |
| 2021 FY | - USD | 113.86% |
| 2021 Q3 | -49.73 Million USD | 9.09% |
| 2021 Q2 | -54.7 Million USD | -33.09% |
| 2020 Q2 | -30.02 Million USD | 80.91% |
| 2020 Q1 | -157.26 Million USD | 10.86% |
| 2020 Q4 | -56.66 Million USD | -56.73% |
| 2020 Q3 | -36.15 Million USD | -20.42% |
| 2020 FY | - USD | 88.61% |
| 2019 Q3 | -669.86 Million CAD | -210.47% |
| 2019 FY | - CAD | -12000.09% |
| 2019 Q4 | -176.42 Million CAD | 73.66% |
| 2019 Q2 | -215.76 Million CAD | -11167.35% |
| 2019 Q1 | 1.94 Million CAD | 124.54% |
| 2018 Q1 | -1.23 Million CAD | -635.19% |
| 2018 Q4 | -7.94 Million CAD | -143.7% |
| 2018 FY | - CAD | -1442.23% |
| 2018 Q3 | -3.26 Million CAD | -502.59% |
| 2018 Q2 | 809.76 Thousand CAD | 165.48% |
| 2017 Q3 | 137.38 Thousand CAD | 106.85% |
| 2017 FY | - CAD | 35.9% |
| 2017 Q4 | 231.06 Thousand CAD | 68.19% |
| 2017 Q2 | -2 Million CAD | -524.8% |
| 2017 Q1 | -320.83 Thousand CAD | -355.2% |
| 2016 Q1 | -324.82 Thousand CAD | 11.42% |
| 2016 FY | - CAD | 70.7% |
| 2016 Q4 | -70.48 Thousand CAD | 83.41% |
| 2016 Q3 | -424.94 Thousand CAD | -16.56% |
| 2016 Q2 | -364.56 Thousand CAD | -12.23% |
| 2015 Q2 | -417.39 Thousand CAD | 25.38% |
| 2015 FY | - CAD | -79.94% |
| 2015 Q4 | -366.68 Thousand CAD | -14.8% |
| 2015 Q3 | -319.4 Thousand CAD | 23.47% |
| 2015 Q1 | -559.38 Thousand CAD | 0.0% |
| 2014 FY | - CAD | -259.75% |
| 2014 Q3 | -76.68 Thousand CAD | -697.61% |
| 2014 Q2 | -9613.92 CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aurora Cannabis Inc. | 20.47 Million CAD | 450.689% |
| Avicanna Inc. | -7.35 Million CAD | -876.145% |
| Avant Brands Inc. | 4.83 Million CAD | 1584.698% |
| Cardiol Therapeutics Inc. | -27.87 Million CAD | -157.533% |
| Crescita Therapeutics Inc. | 45 Thousand CAD | 159655.556% |
| Knight Therapeutics Inc. | 40.89 Million CAD | 275.563% |
| MediPharm Labs Corp. | -10.47 Million CAD | -585.245% |
| OrganiGram Holdings Inc. | -207.61 Million CAD | 65.417% |
| Canopy Growth Corporation | -312.82 Million CAD | 77.048% |
| Willow Biosciences Inc. | -11.06 Million CAD | -549.128% |
| Auxly Cannabis Group Inc. | -10.82 Million CAD | -563.279% |